(Q37849332)

24 August 2017

1 reference

title

Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C? (English)

1 reference

24 August 2017

1 reference

3

1 reference

24 August 2017

Helen Blacklaws

1

1 reference

24 August 2017

Anne Gardner

series ordinal

2

1 reference

24 August 2017

publication date

3 March 2011

1 reference

Journal of Clinical Nursing

24 August 2017

published in

1 reference

24 August 2017

volume

20

1 reference

24 August 2017

issue

9-10

1 reference

24 August 2017

page(s)

1215-1224

1 reference

Nurses, indirect trauma, and prevention

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Anger experiences among hepatitis C patients: relationship to depressive symptoms and health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Diagnosis and treatment of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Psychiatric symptoms during interferon treatment for hepatitis C: experiences from a tertiary care hepatology centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

The phenomenology and treatment of interferon-induced depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Neuropsychiatric adverse effects of interferon-alpha: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Interferon alpha (IFNalpha) and psychiatric syndromes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Irritability: definition, assessment and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

Hepatitis C: a review for primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2702.2010.03494.X

10.1111/J.1365-2702.2010.03494.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference